| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Jun 2024 | 10 Jun 2024 |
| Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 12th June 2024 at 3:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India - 380 055 inter-alia to consider and approve the Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2024 along with Auditor Report. Pursuant to Regulations 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 12th June, 2024, at the registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380055, which commenced at 3:00 P.M. and concluded at 9:40 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report. (As Per BSE Announcement Dated on: 12/06/2024) | ||
| Board Meeting | 6 May 2024 | 8 Apr 2024 |
| Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Friday 26th April 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss and consider inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Friday, 26th April, 2024 at 2:00 P.M., is now rescheduled to Thursday, 2nd May, 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. 3. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. (As Per BSE Announcement Dated on: 25/04/2024) Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May, 2024 Pursuant to the second proviso to Regulation 30(6) of the SEBI (LODR) Regulations, 2015, we hereby inform you the Board of Directors of the Company meeting held today i.e. Thursday, 2nd May, 2024 which commenced at 2:00 P.M., and Concluded at 7:30 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, has decided to Re-schedule the meeting to be held on 6th May, 2024 for discuss and consider, inter-alia: The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. The proposal of sub-division of equity shares of the Company. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. Note that meeting is reschedule due to requirement of expert advice. (As Per BSE Announcement Dated on 02.05.2024) Outcome of Board Meeting held on 6th May, 2024 (As per BSE Announcement Dated on 06/05/2024) | ||
| Board Meeting | 28 Mar 2024 | 29 Mar 2024 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (the Regulations), we hereby inform you that the Rights Issue Committee of Directors of the Company in their meeting held on Thursday, 28th March, 2024 at the Registered Of??ice of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, which commenced at 4:00 P.M. and concluded at 6:00 P.M. inter-alia had considered and approved as per attachment. Read less.. | ||
| Board Meeting | 19 Mar 2024 | 19 Mar 2024 |
| With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 19th March, 2024 the date of closure of the captioned Right Issue, which had opened on Monday, 26th February, 2024 and scheduled to close on Tuesday, 19th March, 2024 has now been extended by the Company from Tuesday, 19th March, 2024 to Wednesday, 20th March, 2024 in order to provide an opportunity to shareholders to exercise their rights in the Rights Issue. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 03:00 P.M. | ||
| Board Meeting | 15 Mar 2024 | 15 Mar 2024 |
| With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 15th March, 2024 the date of closure of the captioned Right Issue, which had opened on Monday, 26th February, 2024 and scheduled to close on Friday, 15th March, 2024 has now been extended by the Company from Friday, 15th March, 2024 to Tuesday, 19th March, 2024 in order to provide an opportunity to shareholders to exercise their rights in the Rights Issue. The meeting of the Board of Directors commenced at 10:00 A.M. and concluded at 11:00 A.M. Read less. | ||
| Board Meeting | 6 Mar 2024 | 6 Mar 2024 |
| Extension of issue closing date of Rights Issue from 07/03/2024 to 15/03/2024. | ||
| Board Meeting | 31 Jan 2024 | 31 Jan 2024 |
| Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in consultation with the Rights Issue Committee in their meeting held today i.e. 31st January, 2024 at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, which commenced at 5:00 P.M. and concluded at 7:00 P.M. inter-alia has considered and approved issue upto 1,29,67,500 Equity Shares of face value of Rs. 10.00/- each for cash at an Issue Price of Rs. 10.00/- per Equity Share aggregating upto Rs. 12,96,75,000/- to all the existing eligible Equity shareholders of the Company on Rights (Rights Issue). The brief term of Rights Issue is approved by the Board is attached herewith as Annexure - I. | ||
| Board Meeting | 15 Dec 2023 | 15 Dec 2023 |
| Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e. Friday, 15th December, 2023 at the Registered Office of the Company which commenced at 5:00 P.M. and concluded at 6:30 P.M inter-alia has considered and approved Appointment of Ms. Madhuri Gurwani as Company secretary and Compliance Officer of the Company w.e.f 15th December, 2023. Appointment Of Company Secretary | ||
| Board Meeting | 8 Dec 2023 | 8 Dec 2023 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e. Friday, 8th December, 2023 at the Registered Office of the Company which commenced at 11:00 A.M. and concluded at 12:00 P.M inter-alia has: 1. Considered and approved increase in Authorised Share Capital upto Rs. 25,00,00,000/- (Rupees Twenty-Five Crores Only) by alteration of the capital clause in the Memorandum of Association of the Company. 2. Decided to hold Extra-Ordinary General Meeting (EGM) of the Shareholders of the Company on Wednesday, 3rd January, 2024 at 12:00 P.M. | ||
| Board Meeting | 18 Oct 2023 | 5 Oct 2023 |
| Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 11th October 2023 at 4:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad-380055 inter-alia to discuss consider and approve: 1. Issue of Equity shares of the Company on Rights basis. 2. Unaudited Financial Results for half year ended on 30th September 2023 along with Limited Review Report. Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company which was to be held on Wednesday, 11th October, 2023 at 4:00 P.M, but due to unavoidable circumstances has been stands postponed on 18th October, 2023 at the same time and venue inter-alia to discuss, consider and approve: 1. Issue of Equity shares of the Company on Rights basis. 2. Unaudited Financial Results for half year ended on 30th September, 2023 along with Limited Review Report. (As per BSE Announcement Dated on 16/10/2023) Outcome of Board Meeting held on today i.e. 18th October, 2023 Submission of Unaudited Financial Results for the half year ended on 30th September, 2023 (As Per BSE Announcement dated on 18.10.2023) | ||
| Board Meeting | 6 Sep 2023 | 6 Sep 2023 |
| Outcome of Board Meeting held today i.e., 6th September, 2023 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
